Abstract LB442: Whole body PBPK/PD modeling to support first-in-human dose selection for GenSci140, a potential best-in-class FRα biparatopic ADC, in patients with cancer
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154754030
Cites:
Cited by:
Related to:
